ADVANCE RESEARCH CHEMICALS has sponsored the creation of one or more 401k plans.
Submission information for form 5500 for 401k plan ADVANCE RESEARCH CHEMICALS 401(K) PLAN
Measure | Date | Value |
---|
2022: ADVANCE RESEARCH CHEMICALS 401(K) PLAN 2022 401k membership |
---|
Total participants, beginning-of-year | 2022-01-01 | 163 |
Total number of active participants reported on line 7a of the Form 5500 | 2022-01-01 | 0 |
Number of retired or separated participants receiving benefits | 2022-01-01 | 0 |
Number of other retired or separated participants entitled to future benefits | 2022-01-01 | 0 |
Total of all active and inactive participants | 2022-01-01 | 0 |
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits | 2022-01-01 | 0 |
Total participants | 2022-01-01 | 0 |
Number of participants with account balances | 2022-01-01 | 0 |
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested | 2022-01-01 | 0 |
2021: ADVANCE RESEARCH CHEMICALS 401(K) PLAN 2021 401k membership |
---|
Total participants, beginning-of-year | 2021-01-01 | 165 |
Total number of active participants reported on line 7a of the Form 5500 | 2021-01-01 | 114 |
Number of retired or separated participants receiving benefits | 2021-01-01 | 1 |
Number of other retired or separated participants entitled to future benefits | 2021-01-01 | 39 |
Total of all active and inactive participants | 2021-01-01 | 154 |
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits | 2021-01-01 | 2 |
Total participants | 2021-01-01 | 156 |
Number of participants with account balances | 2021-01-01 | 130 |
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested | 2021-01-01 | 0 |
2020: ADVANCE RESEARCH CHEMICALS 401(K) PLAN 2020 401k membership |
---|
Total participants, beginning-of-year | 2020-01-01 | 215 |
Total number of active participants reported on line 7a of the Form 5500 | 2020-01-01 | 139 |
Number of retired or separated participants receiving benefits | 2020-01-01 | 0 |
Number of other retired or separated participants entitled to future benefits | 2020-01-01 | 23 |
Total of all active and inactive participants | 2020-01-01 | 162 |
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits | 2020-01-01 | 1 |
Total participants | 2020-01-01 | 163 |
Number of participants with account balances | 2020-01-01 | 137 |
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested | 2020-01-01 | 0 |
2019: ADVANCE RESEARCH CHEMICALS 401(K) PLAN 2019 401k membership |
---|
Total participants, beginning-of-year | 2019-01-01 | 184 |
Total number of active participants reported on line 7a of the Form 5500 | 2019-01-01 | 114 |
Number of retired or separated participants receiving benefits | 2019-01-01 | 0 |
Number of other retired or separated participants entitled to future benefits | 2019-01-01 | 99 |
Total of all active and inactive participants | 2019-01-01 | 213 |
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits | 2019-01-01 | 0 |
Total participants | 2019-01-01 | 213 |
Number of participants with account balances | 2019-01-01 | 197 |
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested | 2019-01-01 | 0 |
2018: ADVANCE RESEARCH CHEMICALS 401(K) PLAN 2018 401k membership |
---|
Total participants, beginning-of-year | 2018-01-01 | 171 |
Total number of active participants reported on line 7a of the Form 5500 | 2018-01-01 | 121 |
Number of retired or separated participants receiving benefits | 2018-01-01 | 0 |
Number of other retired or separated participants entitled to future benefits | 2018-01-01 | 53 |
Total of all active and inactive participants | 2018-01-01 | 174 |
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits | 2018-01-01 | 0 |
Total participants | 2018-01-01 | 174 |
Number of participants with account balances | 2018-01-01 | 150 |
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested | 2018-01-01 | 0 |
2017: ADVANCE RESEARCH CHEMICALS 401(K) PLAN 2017 401k membership |
---|
Total participants, beginning-of-year | 2017-01-01 | 137 |
Number of other retired or separated participants entitled to future benefits | 2017-01-01 | 46 |
Total of all active and inactive participants | 2017-01-01 | 46 |
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits | 2017-01-01 | 0 |
Total participants | 2017-01-01 | 46 |
Number of participants with account balances | 2017-01-01 | 139 |
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested | 2017-01-01 | 0 |
2014: ADVANCE RESEARCH CHEMICALS 401(K) PLAN 2014 401k membership |
---|
Total participants, beginning-of-year | 2014-01-01 | 61 |
Total number of active participants reported on line 7a of the Form 5500 | 2014-01-01 | 50 |
Number of retired or separated participants receiving benefits | 2014-01-01 | 0 |
Number of other retired or separated participants entitled to future benefits | 2014-01-01 | 12 |
Total of all active and inactive participants | 2014-01-01 | 62 |
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits | 2014-01-01 | 0 |
Total participants | 2014-01-01 | 62 |
Number of participants with account balances | 2014-01-01 | 56 |
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested | 2014-01-01 | 0 |
2013: ADVANCE RESEARCH CHEMICALS 401(K) PLAN 2013 401k membership |
---|
Total participants, beginning-of-year | 2013-01-01 | 61 |
Total number of active participants reported on line 7a of the Form 5500 | 2013-01-01 | 50 |
Number of retired or separated participants receiving benefits | 2013-01-01 | 0 |
Number of other retired or separated participants entitled to future benefits | 2013-01-01 | 12 |
Total of all active and inactive participants | 2013-01-01 | 62 |
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits | 2013-01-01 | 0 |
Total participants | 2013-01-01 | 62 |
Number of participants with account balances | 2013-01-01 | 56 |
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested | 2013-01-01 | 0 |
2012: ADVANCE RESEARCH CHEMICALS 401(K) PLAN 2012 401k membership |
---|
Total participants, beginning-of-year | 2012-01-01 | 56 |
Total number of active participants reported on line 7a of the Form 5500 | 2012-01-01 | 45 |
Number of retired or separated participants receiving benefits | 2012-01-01 | 0 |
Number of other retired or separated participants entitled to future benefits | 2012-01-01 | 12 |
Total of all active and inactive participants | 2012-01-01 | 57 |
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits | 2012-01-01 | 0 |
Total participants | 2012-01-01 | 57 |
Number of participants with account balances | 2012-01-01 | 45 |
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested | 2012-01-01 | 0 |
2011: ADVANCE RESEARCH CHEMICALS 401(K) PLAN 2011 401k membership |
---|
Total participants, beginning-of-year | 2011-01-01 | 52 |
Total number of active participants reported on line 7a of the Form 5500 | 2011-01-01 | 42 |
Number of retired or separated participants receiving benefits | 2011-01-01 | 0 |
Number of other retired or separated participants entitled to future benefits | 2011-01-01 | 6 |
Total of all active and inactive participants | 2011-01-01 | 48 |
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits | 2011-01-01 | 0 |
Total participants | 2011-01-01 | 48 |
Number of participants with account balances | 2011-01-01 | 48 |
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested | 2011-01-01 | 0 |
2009: ADVANCE RESEARCH CHEMICALS 401(K) PLAN 2009 401k membership |
---|
Total participants, beginning-of-year | 2009-01-01 | 47 |
Total number of active participants reported on line 7a of the Form 5500 | 2009-01-01 | 33 |
Number of retired or separated participants receiving benefits | 2009-01-01 | 0 |
Number of other retired or separated participants entitled to future benefits | 2009-01-01 | 11 |
Total of all active and inactive participants | 2009-01-01 | 44 |
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits | 2009-01-01 | 0 |
Total participants | 2009-01-01 | 44 |
Number of participants with account balances | 2009-01-01 | 44 |
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested | 2009-01-01 | 0 |
Measure | Date | Value |
---|
2022 : ADVANCE RESEARCH CHEMICALS 401(K) PLAN 2022 401k financial data |
---|
Total transfer of assets from this plan | 2022-12-30 | $5,379,474 |
Total income from all sources (including contributions) | 2022-12-30 | $-2,024,442 |
Total of all expenses incurred | 2022-12-30 | $7,612,282 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2022-12-30 | $7,595,822 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2022-12-30 | $693,989 |
Value of total assets at end of year | 2022-12-30 | $0 |
Value of total assets at beginning of year | 2022-12-30 | $15,016,198 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2022-12-30 | $16,460 |
Total interest from all sources | 2022-12-30 | $8,141 |
Total dividends received (eg from common stock, registered investment company shares) | 2022-12-30 | $203,407 |
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2022-12-30 | Yes |
Value of any plan assets that reverted to the employer resulting from resoluton to terminate the plan | 2022-12-30 | $0 |
Total dividends received from registered investment company shares (eg mutual funds) | 2022-12-30 | $203,407 |
Was this plan covered by a fidelity bond | 2022-12-30 | Yes |
Value of fidelity bond cover | 2022-12-30 | $1,000,000 |
If this is an individual account plan, was there a blackout period | 2022-12-30 | Yes |
Were there any nonexempt tranactions with any party-in-interest | 2022-12-30 | No |
Contributions received from participants | 2022-12-30 | $410,285 |
Participant contributions at end of year | 2022-12-30 | $0 |
Participant contributions at beginning of year | 2022-12-30 | $205,316 |
Participant contributions at end of year | 2022-12-30 | $0 |
Participant contributions at beginning of year | 2022-12-30 | $17,285 |
Income. Received or receivable in cash from other sources (including rollovers) | 2022-12-30 | $23,100 |
Value of other receiveables (less allowance for doubtful accounts) at end of year | 2022-12-30 | $0 |
Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2022-12-30 | $559 |
Administrative expenses (other) incurred | 2022-12-30 | $16,460 |
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2022-12-30 | No |
Value of net income/loss | 2022-12-30 | $-9,636,724 |
Value of net assets at end of year (total assets less liabilities) | 2022-12-30 | $0 |
Value of net assets at beginning of year (total assets less liabilities) | 2022-12-30 | $15,016,198 |
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2022-12-30 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2022-12-30 | No |
Were any leases to which the plan was party in default or uncollectible | 2022-12-30 | No |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2022-12-30 | $0 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2022-12-30 | $13,131,418 |
Value of interest in pooled separate accounts at end of year | 2022-12-30 | $0 |
Value of interest in pooled separate accounts at beginning of year | 2022-12-30 | $1,651,830 |
Interest on participant loans | 2022-12-30 | $8,141 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2022-12-30 | $-2,936,557 |
Net investment gain/loss from pooled separate accounts | 2022-12-30 | $6,578 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2022-12-30 | No |
Was there a failure to transmit to the plan any participant contributions | 2022-12-30 | Yes |
Has the plan failed to provide any benefit when due under the plan | 2022-12-30 | No |
Contributions received in cash from employer | 2022-12-30 | $260,604 |
Employer contributions (assets) at end of year | 2022-12-30 | $0 |
Employer contributions (assets) at beginning of year | 2022-12-30 | $9,790 |
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2022-12-30 | $7,595,822 |
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3 | 2022-12-30 | Yes |
Did the plan have assets held for investment | 2022-12-30 | No |
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2022-12-30 | No |
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2022-12-30 | Yes |
Opinion of an independent qualified public accountant for this plan | 2022-12-30 | Unqualified |
Accountancy firm name | 2022-12-30 | EIDE BAILLY |
Accountancy firm EIN | 2022-12-30 | 450250958 |
2021 : ADVANCE RESEARCH CHEMICALS 401(K) PLAN 2021 401k financial data |
---|
Total income from all sources (including contributions) | 2021-12-31 | $2,405,302 |
Total of all expenses incurred | 2021-12-31 | $320,459 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2021-12-31 | $298,725 |
Value of total corrective distributions | 2021-12-31 | $638 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2021-12-31 | $885,467 |
Value of total assets at end of year | 2021-12-31 | $15,016,198 |
Value of total assets at beginning of year | 2021-12-31 | $12,931,355 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2021-12-31 | $21,096 |
Total interest from all sources | 2021-12-31 | $9,526 |
Total dividends received (eg from common stock, registered investment company shares) | 2021-12-31 | $199,190 |
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2021-12-31 | No |
Total dividends received from registered investment company shares (eg mutual funds) | 2021-12-31 | $199,190 |
Was this plan covered by a fidelity bond | 2021-12-31 | No |
If this is an individual account plan, was there a blackout period | 2021-12-31 | No |
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities | 2021-12-31 | $0 |
Were there any nonexempt tranactions with any party-in-interest | 2021-12-31 | No |
Contributions received from participants | 2021-12-31 | $585,551 |
Participant contributions at end of year | 2021-12-31 | $205,316 |
Participant contributions at beginning of year | 2021-12-31 | $190,627 |
Participant contributions at end of year | 2021-12-31 | $17,285 |
Participant contributions at beginning of year | 2021-12-31 | $0 |
Income. Received or receivable in cash from other sources (including rollovers) | 2021-12-31 | $4,696 |
Value of other receiveables (less allowance for doubtful accounts) at end of year | 2021-12-31 | $559 |
Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2021-12-31 | $297 |
Administrative expenses (other) incurred | 2021-12-31 | $21,096 |
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2021-12-31 | No |
Value of net income/loss | 2021-12-31 | $2,084,843 |
Value of net assets at end of year (total assets less liabilities) | 2021-12-31 | $15,016,198 |
Value of net assets at beginning of year (total assets less liabilities) | 2021-12-31 | $12,931,355 |
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2021-12-31 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2021-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2021-12-31 | No |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2021-12-31 | $13,131,418 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2021-12-31 | $12,201,612 |
Value of interest in pooled separate accounts at end of year | 2021-12-31 | $1,651,830 |
Value of interest in pooled separate accounts at beginning of year | 2021-12-31 | $538,819 |
Interest on participant loans | 2021-12-31 | $9,526 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2021-12-31 | $1,306,418 |
Net investment gain/loss from pooled separate accounts | 2021-12-31 | $4,701 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2021-12-31 | No |
Was there a failure to transmit to the plan any participant contributions | 2021-12-31 | Yes |
Has the plan failed to provide any benefit when due under the plan | 2021-12-31 | No |
Contributions received in cash from employer | 2021-12-31 | $295,220 |
Employer contributions (assets) at end of year | 2021-12-31 | $9,790 |
Employer contributions (assets) at beginning of year | 2021-12-31 | $0 |
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2021-12-31 | $298,725 |
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3 | 2021-12-31 | No |
Did the plan have assets held for investment | 2021-12-31 | Yes |
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2021-12-31 | No |
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2021-12-31 | No |
Opinion of an independent qualified public accountant for this plan | 2021-12-31 | Unqualified |
Accountancy firm name | 2021-12-31 | EIDE BAILLY |
Accountancy firm EIN | 2021-12-31 | 450250958 |
2020 : ADVANCE RESEARCH CHEMICALS 401(K) PLAN 2020 401k financial data |
---|
Total income from all sources (including contributions) | 2020-12-31 | $2,725,499 |
Total of all expenses incurred | 2020-12-31 | $309,090 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2020-12-31 | $293,572 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2020-12-31 | $867,454 |
Value of total assets at end of year | 2020-12-31 | $12,931,355 |
Value of total assets at beginning of year | 2020-12-31 | $10,514,946 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2020-12-31 | $15,518 |
Total interest from all sources | 2020-12-31 | $8,420 |
Total dividends received (eg from common stock, registered investment company shares) | 2020-12-31 | $154,050 |
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2020-12-31 | No |
Total dividends received from registered investment company shares (eg mutual funds) | 2020-12-31 | $154,050 |
Was this plan covered by a fidelity bond | 2020-12-31 | No |
If this is an individual account plan, was there a blackout period | 2020-12-31 | No |
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities | 2020-12-31 | $0 |
Were there any nonexempt tranactions with any party-in-interest | 2020-12-31 | No |
Contributions received from participants | 2020-12-31 | $580,011 |
Participant contributions at end of year | 2020-12-31 | $190,627 |
Participant contributions at beginning of year | 2020-12-31 | $139,510 |
Value of other receiveables (less allowance for doubtful accounts) at end of year | 2020-12-31 | $297 |
Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2020-12-31 | $627 |
Administrative expenses (other) incurred | 2020-12-31 | $15,518 |
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2020-12-31 | No |
Value of net income/loss | 2020-12-31 | $2,416,409 |
Value of net assets at end of year (total assets less liabilities) | 2020-12-31 | $12,931,355 |
Value of net assets at beginning of year (total assets less liabilities) | 2020-12-31 | $10,514,946 |
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2020-12-31 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2020-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2020-12-31 | No |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2020-12-31 | $12,201,612 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2020-12-31 | $9,699,598 |
Value of interest in pooled separate accounts at end of year | 2020-12-31 | $538,819 |
Value of interest in pooled separate accounts at beginning of year | 2020-12-31 | $675,211 |
Interest on participant loans | 2020-12-31 | $8,420 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2020-12-31 | $1,686,770 |
Net investment gain/loss from pooled separate accounts | 2020-12-31 | $8,805 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2020-12-31 | No |
Was there a failure to transmit to the plan any participant contributions | 2020-12-31 | No |
Has the plan failed to provide any benefit when due under the plan | 2020-12-31 | No |
Contributions received in cash from employer | 2020-12-31 | $287,443 |
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2020-12-31 | $293,572 |
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3 | 2020-12-31 | No |
Did the plan have assets held for investment | 2020-12-31 | Yes |
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2020-12-31 | No |
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2020-12-31 | No |
Opinion of an independent qualified public accountant for this plan | 2020-12-31 | Unqualified |
Accountancy firm name | 2020-12-31 | EIDE BAILLY |
Accountancy firm EIN | 2020-12-31 | 450250958 |
2019 : ADVANCE RESEARCH CHEMICALS 401(K) PLAN 2019 401k financial data |
---|
Total income from all sources (including contributions) | 2019-12-31 | $2,929,405 |
Total of all expenses incurred | 2019-12-31 | $413,435 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2019-12-31 | $389,457 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2019-12-31 | $798,844 |
Value of total assets at end of year | 2019-12-31 | $10,514,946 |
Value of total assets at beginning of year | 2019-12-31 | $7,998,976 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2019-12-31 | $23,978 |
Total interest from all sources | 2019-12-31 | $7,315 |
Total dividends received (eg from common stock, registered investment company shares) | 2019-12-31 | $131,315 |
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2019-12-31 | No |
Total dividends received from registered investment company shares (eg mutual funds) | 2019-12-31 | $131,315 |
Was this plan covered by a fidelity bond | 2019-12-31 | No |
If this is an individual account plan, was there a blackout period | 2019-12-31 | No |
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities | 2019-12-31 | $0 |
Were there any nonexempt tranactions with any party-in-interest | 2019-12-31 | No |
Contributions received from participants | 2019-12-31 | $491,018 |
Participant contributions at end of year | 2019-12-31 | $139,510 |
Participant contributions at beginning of year | 2019-12-31 | $107,539 |
Value of other receiveables (less allowance for doubtful accounts) at end of year | 2019-12-31 | $627 |
Administrative expenses (other) incurred | 2019-12-31 | $23,978 |
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2019-12-31 | No |
Value of net income/loss | 2019-12-31 | $2,515,970 |
Value of net assets at end of year (total assets less liabilities) | 2019-12-31 | $10,514,946 |
Value of net assets at beginning of year (total assets less liabilities) | 2019-12-31 | $7,998,976 |
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2019-12-31 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2019-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2019-12-31 | No |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2019-12-31 | $9,699,598 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2019-12-31 | $7,559,491 |
Value of interest in pooled separate accounts at end of year | 2019-12-31 | $675,211 |
Value of interest in pooled separate accounts at beginning of year | 2019-12-31 | $331,946 |
Interest on participant loans | 2019-12-31 | $7,315 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2019-12-31 | $1,983,054 |
Net investment gain/loss from pooled separate accounts | 2019-12-31 | $8,877 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2019-12-31 | No |
Was there a failure to transmit to the plan any participant contributions | 2019-12-31 | No |
Has the plan failed to provide any benefit when due under the plan | 2019-12-31 | No |
Contributions received in cash from employer | 2019-12-31 | $307,826 |
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2019-12-31 | $389,457 |
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3 | 2019-12-31 | No |
Did the plan have assets held for investment | 2019-12-31 | Yes |
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2019-12-31 | No |
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2019-12-31 | No |
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d) | 2019-12-31 | Yes |
Opinion of an independent qualified public accountant for this plan | 2019-12-31 | Disclaimer |
Accountancy firm name | 2019-12-31 | EIDE BAILLY |
Accountancy firm EIN | 2019-12-31 | 450250958 |
2018 : ADVANCE RESEARCH CHEMICALS 401(K) PLAN 2018 401k financial data |
---|
Total income from all sources (including contributions) | 2018-12-31 | $18,371 |
Total of all expenses incurred | 2018-12-31 | $162,869 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2018-12-31 | $144,223 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2018-12-31 | $671,873 |
Value of total assets at end of year | 2018-12-31 | $7,998,976 |
Value of total assets at beginning of year | 2018-12-31 | $8,143,474 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2018-12-31 | $18,646 |
Total interest from all sources | 2018-12-31 | $7,606 |
Total dividends received (eg from common stock, registered investment company shares) | 2018-12-31 | $213,663 |
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2018-12-31 | No |
Total dividends received from registered investment company shares (eg mutual funds) | 2018-12-31 | $213,663 |
Was this plan covered by a fidelity bond | 2018-12-31 | No |
If this is an individual account plan, was there a blackout period | 2018-12-31 | No |
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities | 2018-12-31 | $0 |
Were there any nonexempt tranactions with any party-in-interest | 2018-12-31 | No |
Contributions received from participants | 2018-12-31 | $438,238 |
Participant contributions at end of year | 2018-12-31 | $107,539 |
Participant contributions at beginning of year | 2018-12-31 | $201,918 |
Administrative expenses (other) incurred | 2018-12-31 | $18,646 |
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2018-12-31 | No |
Value of net income/loss | 2018-12-31 | $-144,498 |
Value of net assets at end of year (total assets less liabilities) | 2018-12-31 | $7,998,976 |
Value of net assets at beginning of year (total assets less liabilities) | 2018-12-31 | $8,143,474 |
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2018-12-31 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2018-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2018-12-31 | No |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2018-12-31 | $7,559,491 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2018-12-31 | $7,586,826 |
Value of interest in pooled separate accounts at end of year | 2018-12-31 | $331,946 |
Value of interest in pooled separate accounts at beginning of year | 2018-12-31 | $354,730 |
Interest on participant loans | 2018-12-31 | $7,606 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2018-12-31 | $-880,034 |
Net investment gain/loss from pooled separate accounts | 2018-12-31 | $5,263 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2018-12-31 | No |
Was there a failure to transmit to the plan any participant contributions | 2018-12-31 | No |
Has the plan failed to provide any benefit when due under the plan | 2018-12-31 | No |
Contributions received in cash from employer | 2018-12-31 | $233,635 |
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2018-12-31 | $144,223 |
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3 | 2018-12-31 | No |
Did the plan have assets held for investment | 2018-12-31 | Yes |
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2018-12-31 | No |
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2018-12-31 | No |
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d) | 2018-12-31 | Yes |
Opinion of an independent qualified public accountant for this plan | 2018-12-31 | Disclaimer |
Accountancy firm name | 2018-12-31 | EIDE BAILLY |
Accountancy firm EIN | 2018-12-31 | 450250958 |
2017 : ADVANCE RESEARCH CHEMICALS 401(K) PLAN 2017 401k financial data |
---|
Total income from all sources (including contributions) | 2017-12-31 | $1,840,950 |
Total of all expenses incurred | 2017-12-31 | $274,335 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2017-12-31 | $259,810 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2017-12-31 | $595,354 |
Value of total assets at end of year | 2017-12-31 | $8,143,474 |
Value of total assets at beginning of year | 2017-12-31 | $6,576,859 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2017-12-31 | $14,525 |
Total interest from all sources | 2017-12-31 | $8,785 |
Total dividends received (eg from common stock, registered investment company shares) | 2017-12-31 | $121,662 |
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2017-12-31 | No |
Total dividends received from registered investment company shares (eg mutual funds) | 2017-12-31 | $121,662 |
Was this plan covered by a fidelity bond | 2017-12-31 | Yes |
Value of fidelity bond cover | 2017-12-31 | $1,000,000 |
If this is an individual account plan, was there a blackout period | 2017-12-31 | No |
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities | 2017-12-31 | $0 |
Were there any nonexempt tranactions with any party-in-interest | 2017-12-31 | No |
Contributions received from participants | 2017-12-31 | $378,372 |
Participant contributions at end of year | 2017-12-31 | $201,918 |
Participant contributions at beginning of year | 2017-12-31 | $179,537 |
Administrative expenses (other) incurred | 2017-12-31 | $14,525 |
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2017-12-31 | No |
Value of net income/loss | 2017-12-31 | $1,566,615 |
Value of net assets at end of year (total assets less liabilities) | 2017-12-31 | $8,143,474 |
Value of net assets at beginning of year (total assets less liabilities) | 2017-12-31 | $6,576,859 |
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2017-12-31 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2017-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2017-12-31 | No |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2017-12-31 | $7,586,826 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2017-12-31 | $5,911,351 |
Value of interest in pooled separate accounts at end of year | 2017-12-31 | $354,730 |
Value of interest in pooled separate accounts at beginning of year | 2017-12-31 | $485,971 |
Interest on participant loans | 2017-12-31 | $8,785 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2017-12-31 | $1,110,230 |
Net investment gain/loss from pooled separate accounts | 2017-12-31 | $4,919 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2017-12-31 | No |
Was there a failure to transmit to the plan any participant contributions | 2017-12-31 | No |
Has the plan failed to provide any benefit when due under the plan | 2017-12-31 | No |
Contributions received in cash from employer | 2017-12-31 | $216,982 |
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2017-12-31 | $259,810 |
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3 | 2017-12-31 | No |
Did the plan have assets held for investment | 2017-12-31 | Yes |
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2017-12-31 | No |
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2017-12-31 | No |
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d) | 2017-12-31 | Yes |
Opinion of an independent qualified public accountant for this plan | 2017-12-31 | Disclaimer |
Accountancy firm name | 2017-12-31 | EIDE BAILLY |
Accountancy firm EIN | 2017-12-31 | 450250958 |
2014 : ADVANCE RESEARCH CHEMICALS 401(K) PLAN 2014 401k financial data |
---|
Transfers to/from the plan | 2014-12-31 | $14,170 |
Total income from all sources | 2014-12-31 | $700,243 |
Expenses. Total of all expenses incurred | 2014-12-31 | $61,039 |
Benefits paid (including direct rollovers) | 2014-12-31 | $59,570 |
Total plan assets at end of year | 2014-12-31 | $4,155,259 |
Total plan assets at beginning of year | 2014-12-31 | $3,501,885 |
Value of fidelity bond covering the plan | 2014-12-31 | $1,000,000 |
Total contributions received or receivable from participants | 2014-12-31 | $222,626 |
Expenses. Other expenses not covered elsewhere | 2014-12-31 | $1,469 |
Contributions received from other sources (not participants or employers) | 2014-12-31 | $0 |
Other income received | 2014-12-31 | $339,867 |
Net income (gross income less expenses) | 2014-12-31 | $639,204 |
Net plan assets at end of year (total assets less liabilities) | 2014-12-31 | $4,155,259 |
Net plan assets at beginning of year (total assets less liabilities) | 2014-12-31 | $3,501,885 |
Assets. Value of participant loans | 2014-12-31 | $0 |
Total contributions received or receivable from employer(s) | 2014-12-31 | $137,750 |
Value of certain deemed distributions of participant loans | 2014-12-31 | $0 |
Value of corrective distributions | 2014-12-31 | $0 |
Funding deficiency by the employer to the plan for this plan year | 2014-12-31 | $0 |
Minimum employer required contribution for this plan year | 2014-12-31 | $0 |
Amount contributed by the employer to the plan for this plan year | 2014-12-31 | $0 |
2013 : ADVANCE RESEARCH CHEMICALS 401(K) PLAN 2013 401k financial data |
---|
Transfers to/from the plan | 2013-12-31 | $0 |
Total income from all sources | 2013-12-31 | $1,053,126 |
Expenses. Total of all expenses incurred | 2013-12-31 | $64,523 |
Benefits paid (including direct rollovers) | 2013-12-31 | $64,173 |
Total plan assets at end of year | 2013-12-31 | $3,501,885 |
Total plan assets at beginning of year | 2013-12-31 | $2,513,282 |
Value of fidelity bond covering the plan | 2013-12-31 | $1,000,000 |
Total contributions received or receivable from participants | 2013-12-31 | $216,916 |
Expenses. Other expenses not covered elsewhere | 2013-12-31 | $350 |
Contributions received from other sources (not participants or employers) | 2013-12-31 | $0 |
Other income received | 2013-12-31 | $710,158 |
Net income (gross income less expenses) | 2013-12-31 | $988,603 |
Net plan assets at end of year (total assets less liabilities) | 2013-12-31 | $3,501,885 |
Net plan assets at beginning of year (total assets less liabilities) | 2013-12-31 | $2,513,282 |
Assets. Value of participant loans | 2013-12-31 | $212,059 |
Total contributions received or receivable from employer(s) | 2013-12-31 | $126,052 |
Value of certain deemed distributions of participant loans | 2013-12-31 | $0 |
Value of corrective distributions | 2013-12-31 | $0 |
Funding deficiency by the employer to the plan for this plan year | 2013-12-31 | $0 |
Minimum employer required contribution for this plan year | 2013-12-31 | $0 |
Amount contributed by the employer to the plan for this plan year | 2013-12-31 | $0 |
2012 : ADVANCE RESEARCH CHEMICALS 401(K) PLAN 2012 401k financial data |
---|
Transfers to/from the plan | 2012-12-31 | $0 |
Total income from all sources | 2012-12-31 | $537,735 |
Expenses. Total of all expenses incurred | 2012-12-31 | $4,350 |
Benefits paid (including direct rollovers) | 2012-12-31 | $4,000 |
Total plan assets at end of year | 2012-12-31 | $2,513,282 |
Total plan assets at beginning of year | 2012-12-31 | $1,979,897 |
Value of fidelity bond covering the plan | 2012-12-31 | $1,000,000 |
Total contributions received or receivable from participants | 2012-12-31 | $174,381 |
Expenses. Other expenses not covered elsewhere | 2012-12-31 | $350 |
Contributions received from other sources (not participants or employers) | 2012-12-31 | $0 |
Other income received | 2012-12-31 | $255,637 |
Net income (gross income less expenses) | 2012-12-31 | $533,385 |
Net plan assets at end of year (total assets less liabilities) | 2012-12-31 | $2,513,282 |
Net plan assets at beginning of year (total assets less liabilities) | 2012-12-31 | $1,979,897 |
Assets. Value of participant loans | 2012-12-31 | $202,364 |
Total contributions received or receivable from employer(s) | 2012-12-31 | $107,717 |
Value of certain deemed distributions of participant loans | 2012-12-31 | $0 |
Value of corrective distributions | 2012-12-31 | $0 |
Funding deficiency by the employer to the plan for this plan year | 2012-12-31 | $0 |
Minimum employer required contribution for this plan year | 2012-12-31 | $0 |
Amount contributed by the employer to the plan for this plan year | 2012-12-31 | $0 |
2011 : ADVANCE RESEARCH CHEMICALS 401(K) PLAN 2011 401k financial data |
---|
Transfers to/from the plan | 2011-12-31 | $0 |
Total income from all sources | 2011-12-31 | $149,817 |
Expenses. Total of all expenses incurred | 2011-12-31 | $45,746 |
Benefits paid (including direct rollovers) | 2011-12-31 | $45,186 |
Total plan assets at end of year | 2011-12-31 | $1,979,897 |
Total plan assets at beginning of year | 2011-12-31 | $1,875,826 |
Value of fidelity bond covering the plan | 2011-12-31 | $1,000,000 |
Total contributions received or receivable from participants | 2011-12-31 | $149,368 |
Expenses. Other expenses not covered elsewhere | 2011-12-31 | $560 |
Contributions received from other sources (not participants or employers) | 2011-12-31 | $0 |
Other income received | 2011-12-31 | $-103,102 |
Net income (gross income less expenses) | 2011-12-31 | $104,071 |
Net plan assets at end of year (total assets less liabilities) | 2011-12-31 | $1,979,897 |
Net plan assets at beginning of year (total assets less liabilities) | 2011-12-31 | $1,875,826 |
Assets. Value of participant loans | 2011-12-31 | $199,492 |
Total contributions received or receivable from employer(s) | 2011-12-31 | $103,551 |
Value of certain deemed distributions of participant loans | 2011-12-31 | $0 |
Value of corrective distributions | 2011-12-31 | $0 |
Funding deficiency by the employer to the plan for this plan year | 2011-12-31 | $0 |
Minimum employer required contribution for this plan year | 2011-12-31 | $0 |
Amount contributed by the employer to the plan for this plan year | 2011-12-31 | $0 |
2010 : ADVANCE RESEARCH CHEMICALS 401(K) PLAN 2010 401k financial data |
---|
Transfers to/from the plan | 2010-12-31 | $0 |
Total income from all sources | 2010-12-31 | $431,743 |
Expenses. Total of all expenses incurred | 2010-12-31 | $24,452 |
Benefits paid (including direct rollovers) | 2010-12-31 | $23,752 |
Total plan assets at end of year | 2010-12-31 | $1,875,826 |
Total plan assets at beginning of year | 2010-12-31 | $1,468,535 |
Value of fidelity bond covering the plan | 2010-12-31 | $1,000,000 |
Total contributions received or receivable from participants | 2010-12-31 | $132,841 |
Expenses. Other expenses not covered elsewhere | 2010-12-31 | $700 |
Contributions received from other sources (not participants or employers) | 2010-12-31 | $0 |
Other income received | 2010-12-31 | $208,908 |
Net income (gross income less expenses) | 2010-12-31 | $407,291 |
Net plan assets at end of year (total assets less liabilities) | 2010-12-31 | $1,875,826 |
Net plan assets at beginning of year (total assets less liabilities) | 2010-12-31 | $1,468,535 |
Assets. Value of participant loans | 2010-12-31 | $226,137 |
Total contributions received or receivable from employer(s) | 2010-12-31 | $89,994 |
Value of certain deemed distributions of participant loans | 2010-12-31 | $0 |
Value of corrective distributions | 2010-12-31 | $0 |
Funding deficiency by the employer to the plan for this plan year | 2010-12-31 | $0 |
Minimum employer required contribution for this plan year | 2010-12-31 | $0 |
Amount contributed by the employer to the plan for this plan year | 2010-12-31 | $0 |
2009 : ADVANCE RESEARCH CHEMICALS 401(K) PLAN 2009 401k financial data |
---|
Funding deficiency by the employer to the plan for this plan year | 2009-12-31 | $0 |
Minimum employer required contribution for this plan year | 2009-12-31 | $0 |
Amount contributed by the employer to the plan for this plan year | 2009-12-31 | $0 |